Yu-Waye Chu, Senior VP Clinical Development at FATE THERAPEUTICS INC (FATE), sold 7,512 shares at $48.44 ($364K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Open-market sale of $364k FATE by Senior VP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.44 | 3,547 | $172K | 47.2% |
| 2 | $48.44 | 3,547 | $172K | 47.2% |
| 3 | $49.10 | 418 | $21K | 5.6% |
| Total | $48.48 avg | 7,512 | $364K | 100% |
| Filing → |
| FATE | SELL | 2023-04-19 | $17K | — | Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |